Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Five months ago, J&J also revealed its plan to spend $2 billion over the next 10 years to operate a 160,000-square-foot ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...

A company that formulates pharmaceuticals in a sterile environment is spending almost $30 million to expand its headquarters ...

The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufactu ...

ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...